Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
—
—
—
—
Grew
—
1 Year
Score—
Net Growth—
Net Trend—
Net Income Consistency—
Rev Growth—
Rev TrendGrew
Revenue Consistency—
5 Years
6.0
96.77%
67%
—
170.37%
40%
—
5 Years
Score6.0
Net Growth96.77%
Net Trend67%
Net Income Consistency—
Rev Growth170.37%
Rev Trend40%
Revenue Consistency—
Explore the 2021 public Archive ranking →
Where NovaBridge Biosciences has ranked, year by year
Measure
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. NBP does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-22 | $ 1.33 | — |
1 Year2025-10-22 | $ 4.82 | -72.41% |
5 Years2021-10-22 | $ 67.43 | -98.03% |
All Time2020-01-17 | $ 12.50 | -89.36% |
| Period | Last Price2026-10-22 | 1 Year2025-10-22 | 5 Years2021-10-22 | All Time2020-01-17 |
|---|---|---|---|---|
| Price | $ 1.33 | $ 4.82 | $ 67.43 | $ 12.50 |
| Return | — | -72.41% | -98.03% | -89.36% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 237M | -$ 75M | $ 190M |
| 2025 | $ 0.00 | $ 30M | |
| 2024 | $ 0.00 | -$ 162M | $ 1.26B |
| 2023 | $ 4M | -$ 1.46B | $ 311M |
| 2022 | -$ 10M | -$ 967M | $ 3.44B |
| 2021 | $ 88M | -$ 2.33B | $ 670M |
| IPO2020 | $ 470M | $ 4.79B |
Membership
Explore NBP with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,119 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
